CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Novo Nordisk As Company Snapshot
Novo Nordisk As operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novo Nordisk As with three other pharmaceutical manufacturers in Europe: Lonza Group AG of SWITZERLAND (2019 sales of 5.92 billion Swiss Francs [US$6.29 billion] of which 70% was Pharma&Biotech), Merck KGaA of GERMANY (16.15 billion Euros [US$18.25 billion] of which 42% was Life Science), and AstraZeneca PLC which is based in UNITED KINGDOM (£19.06 billion [US$24.07 billion] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2019, sales at Novo Nordisk As were 122.02 billion Danish Kroner (US$18.51 billion). This is an increase of 9.1% versus 2018, when the company's sales were 111.83 billion Danish Kroner. Sales of Diabetes and Obesity saw an increase of 9.5% in 2019, from 93.90 billion Danish Kroner to 102.84 billion Danish Kroner.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Novo Nordisk As
  Stock Performance Chart for Novo Nordisk As
 
  Stock Data: Recent Stock Performance:
  Current Price (7/10/2020): 431.85
(Figures in Danish Kroner)
1 Week -1.1%   13 Weeks -0.1%  
4 Weeks 6.2%   52 Weeks 35.5%  
 
Novo Nordisk As Key Data:
  Ticker: NOVOB Country: Denmark
  Exchanges: CPH OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 122,021,000,000
(Year Ending Jan 2020).
Employees: 42,703
  Currency: Danish Kroner Market Cap: 993,930,413,400
  Fiscal Yr Ends: December Shares Outstanding: 2,301,564,000
  Share Type: B Stamaktie Closely Held Shares: 686,789,000
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.